192 related articles for article (PubMed ID: 17441989)
21. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
[TBL] [Abstract][Full Text] [Related]
22. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
23. [Alzheimer's disease: cellular and molecular aspects].
Octave JN; Pierrot N
Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
[TBL] [Abstract][Full Text] [Related]
24. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
Iqbal K; Grundke-Iqbal I
J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
[TBL] [Abstract][Full Text] [Related]
26. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
27. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
29. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
[TBL] [Abstract][Full Text] [Related]
31. Neurofibrillary tangles and tau phosphorylation.
Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G
Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842
[TBL] [Abstract][Full Text] [Related]
32. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
33. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
34. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis.
Köhler C; Dinekov M; Götz J
Neurobiol Dis; 2014 Nov; 71():169-79. PubMed ID: 25073087
[TBL] [Abstract][Full Text] [Related]
35. The relation between tau pathology and granulovacuolar degeneration of neurons.
Puladi B; Dinekov M; Arzberger T; Taubert M; Köhler C
Neurobiol Dis; 2021 Jan; 147():105138. PubMed ID: 33069844
[TBL] [Abstract][Full Text] [Related]
36. Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice.
Götz J; Nitsch RM
Neuroreport; 2001 Jul; 12(9):2007-16. PubMed ID: 11435938
[TBL] [Abstract][Full Text] [Related]
37. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles.
Augustinack JC; Sanders JL; Tsai LH; Hyman BT
J Neuropathol Exp Neurol; 2002 Jun; 61(6):557-64. PubMed ID: 12071639
[TBL] [Abstract][Full Text] [Related]
38. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of tau-induced neurodegeneration.
Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
[TBL] [Abstract][Full Text] [Related]
40. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE
FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
